RYE BROOK, N.Y.–(BUSINESS WIRE)–May 4, 2017– Xylem Inc. (NYSE:XYL), a leading global water company dedicated to solving the world’s most challenging water issues, announced today that its Senior Vice President and Chief Financial Officer Mark Rajkowski and Manager of Investor Relations Matt Latino will participate in group discussions at the Oppenheimer 12th Annual Industrial Growth... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced that it will webcast the company’s presentation at the Bank of America Merrill Lynch Health Care Conference in Las Vegas, Nevada, on May 18, 2017. The live webcast is scheduled to begin at 10:40 AM PT and will feature a brief overview of the company by Marc Stapley, Executive Vice President... Read more
Basel, 04 May 2017 Save the date: Roche Analyst Event at ISTH 2017 Monday, 10 July 2017, 6:30pm CEST We kindly invite investors and analysts to participate in an analyst briefing during the International Society on Thrombosis and Hemostasis Congress (ISTH) in Berlin 8 – 13 July 2017. During the briefing, Roche will discuss new... Read more
BERWYN, Pa., May 3, 2017 /PRNewswire/ — AMETEK, Inc. (NYSE: AME) will present at Wells Fargo Securities 2017 Industrials Conference on Wednesday, May 10, 2017. David Zapico, Chief Executive Officer, will represent the Company. AMETEK’s presentation is scheduled for 10:00 AM ET. The presentation will be simultaneously webcast over the Internet. The live audio webcast... Read more
AUSTIN, Texas, May 3, 2017 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it has received FDA clearance for the ARIES®Bordetella Assay for direct detection and identification of Bordetella pertussis (B. pertussis) and Bordetella parapertussis (B. parapertussis) nucleic acid in nasopharyngeal swab specimens obtained from individuals suspected of having a respiratory tract infection attributable to... Read more
AUSTIN, Texas, May 3, 2017 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it has received FDA clearance for the ARIES®Bordetella Assay for direct detection and identification of Bordetella pertussis (B. pertussis) and Bordetella parapertussis (B. parapertussis) nucleic acid in nasopharyngeal swab specimens obtained from individuals suspected of having a respiratory tract infection attributable to... Read more
WARREN, N.J., May 2, 2017 /PRNewswire/ — Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens will be presenting and exhibiting at the 2017 Food Safety Summit. The conference will at the Donald Stevens Convention Center in Rosemont, Illinois from May 8-11th. Dr.... Read more
Chalfont St. Giles, UK, 2 May 2017 – Broadening its range of diagnostic options for clinicians and their patients, GE Healthcare announced today that it has received an indication approval from the U.S. Food and Drug Administration (FDA) for its imaging agent Visipaque™ (iodixanol) Injection. Visipaque 320 mg Iodine/mL is an iso-osmolar agent that is... Read more
SAN FRANCISCO, Calif. – May 1, 2017 – Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, today announced the appointment of Mark Daniels to the newly-created position of chief ethics and compliance officer. Mr. Daniels will maintain his current position as Twist Bioscience’s general counsel, and in his expanded role,... Read more
FOR MORE INFORMATION: Company Contact: Jill Blumhoff Chief Financial Officer & Vice President of Finance Phone: 765.497.8381 jblumhoff@BASinc.com WEST LAFAYETTE, IN, May 1, 2017 — Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced its Board of Directors has appointed Dr. Peter T. Kissinger, founder and former Executive Chairman and CEO of BASi, as... Read more